HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis
Author(s) -
Julio MadrigalMatute,
Carlos Ernesto FernandezGarcia,
Carmen GómezGuerrero,
Óscar López-Franco,
Begoña MuñozGarcía,
Jesús Egido,
Luis Miguel BlancoColio,
José Luis Martı́n-Ventura
Publication year - 2012
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvs158
Subject(s) - oxidative stress , heat shock protein , hsp90 , protein kinase a , nadph oxidase , oxidative phosphorylation , inflammation , reactive oxygen species , chemistry , microbiology and biotechnology , biochemistry , cancer research , pharmacology , kinase , biology , immunology , gene
Reactive oxygen species (ROS) participate in atherogenesis through different mechanisms including oxidative stress and inflammation. Proteins implicated in both processes, such as mitogen-activated protein kinase kinase (MEK) and some NADPH oxidase (NOX) subunits, are heat shock protein-90 (HSP90) client proteins. In this work, we investigated the antioxidant properties of the HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in experimental atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom